Study on human serum albumin modified by glucose with proteomic technique

Bo Li*, Bo Peng, Dingyu Hu, Yulin Deng

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Advanced glycation end products (AGEs) are a heterogeneous group of complex compounds which may play a role in the pathogenesis of chronic complications associated with diabetes complications, renal failure and aging. Human Serum Albumin (HSA) is the most abundant protein in blood serum. Glucose has the ability to modify HSA and other proteins through glycation. This study was carried out on glycated HSA which was analyzed by LC/MS with the aim of identifying specific peptides. Analysis of the LC/MS data showed that there were differences between peptides of glycated and normal HSA. Modification sites of glycated peptides were also studied. These typical peptides were considered as biomarkers for clinical diagnose of diabetes and aging.

Original languageEnglish
Pages (from-to)425-429
Number of pages5
JournalChemistry Bulletin / Huaxue Tongbao
Volume71
Issue number6
Publication statusPublished - 2008

Keywords

  • Glycation
  • Human serum albumin
  • LC/MS
  • Modification site

Fingerprint

Dive into the research topics of 'Study on human serum albumin modified by glucose with proteomic technique'. Together they form a unique fingerprint.

Cite this